Can Injective Coin Hit $60 After ETF Approval?

Nasdaq approved the first staked INJ exchange-traded fund, trading under ticker INJC, giving traditional brokerage users direct exposure to Injective without managing wallets or validator keys. The listing marks another step in Wall Street's packaging of crypto assets for mainstream finance, with institutional custodians handling staking on behalf of shareholders. Injective's native token has drawn renewed search interest following the approval, though the article frames the development around the tradeoff between convenience and ceding control of network keys. The approval matters as a signal that staking-based crypto products are gaining acceptance on major U.S. exchanges. What to watch next is whether the ETF attracts meaningful inflows and whether INJ can build on the attention toward the $60 level.